In 2017, we saw the defeat of efforts to repeal the Affordable Care Act, the cancellation of the Medicare Part B Drug Reimbursement Project proposed by CMS, extended flexibilities in the MACRA program for physicians and small practices, and more. It is clearer than ever that action taken by Congress and regulatory agencies directly impacts rheumatology practices and patients.
On Sunday afternoon at 1:00 pm, Angus Worthing, MD, Chair of the ACR Government Affairs Committee, will lead a discussion about how medicine and rheumatology have fared over the last year, and the possible effects on your practice. Dr. Worthing has led the government affairs team and has become the leading voice for rheumatology and patients on Capitol Hill.
This session will include expert review of the Alternative Payment Model the ACR has been working on for rheumatologists and what life under the catch-all Merit-Based Incentive Payment System (MIPS) will be like for rheumatologists, as well as how the ACR can help.
The Government Affairs Committee will also host a special guest lawmaker from Capitol Hill to discuss the outlook as a new set of lawmakers convene for the 116th Congress starting in January.